Legal protection of three-dimensional trademarks: comments of the Senior Partner at «A.Zalesov & Partners» Patent & Law Firm Irina Ozolina for Garant.ru portal

On December 21-22, 2021, the XXX anniversary International Conference «Three Decades of Russian Media Legislation: Results and Prospects» took place, organized by the International Scientific and Educational Center «UNESCO Chair on Copyright, Related, Cultural and Information Rights», as well as the Faculty of Law, and the Faculty of Communications, Media and Design of the Higher School of Economics.

The founders of «Double Data» have presented the , in which they published rankings of IP law firms that represented clients in the Intellectual Property Court, based on the  data of kad.arbirtr.ru.

On December 24, 2021, the Federation Council of the Federal Assembly of the Russian Federation approved the Federal Law «On the Accession of the Russian Federation to the Geneva Act of the Lisbon Agreement on Appellations of Origin and Geographical Indications».

On February 08, 2022, the affiliate session of «A.Zalesov & Partners» - «Patent disputes in pharma: a letter of the law vs extreme necessity» - will take place within the framework of the Distant & Digital conference.

The article by patent attorney and advocate Aleksey Zalesov was published in the December issue of the scientific and practical magazine «Intellectual Property. Industrial Property» No. 12/ 2021.

On December 06, 2021, the Russian IP Court ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm - «Geropharm» LLC, having  canceled the decision of Rospatent dated July 28, 2017, on the invalidation action regarding grant of RU patent No. 2564104 for the invention of «Long-acting Insulin Compositions» (patent owner - «SANOFI» Company) and sent the case to Rospatent for reconsideration.